These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12479631)

  • 1. The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy.
    Hildebolt CF; Pilgram TK; Yokoyama-Crothers N; Vannier MW; Dotson M; Muckerman J; Armamento-Villareal R; Hauser J; Cohen S; Kardaris EE; Hanes P; Shrout MK; Civitelli R
    J Periodontol; 2002 Nov; 73(11):1279-84. PubMed ID: 12479631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.
    Civitelli R; Pilgram TK; Dotson M; Muckerman J; Lewandowski N; Armamento-Villareal R; Yokoyama-Crothers N; Kardaris EE; Hauser J; Cohen S; Hildebolt CF
    Arch Intern Med; 2002 Jun; 162(12):1409-15. PubMed ID: 12076241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar bone height and postcranial bone mineral density: negative effects of cigarette smoking and parity.
    Hildebolt CF; Pilgram TK; Yokoyama-Crothers N; Vannier MW; Dotson M; Muckerman J; Hauser J; Cohen S; Kardaris EE; Hanes P; Shrout MK; Civitelli R
    J Periodontol; 2000 May; 71(5):683-9. PubMed ID: 10872947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur.
    Duan Y; Tabensky A; DeLuca V; Seeman E
    Bone; 1997 Nov; 21(5):447-51. PubMed ID: 9356739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
    Sawada K; Morishige K; Ohmichi M; Nishio Y; Yamamoto T; Hayakawa J; Mabuchi S; Isobe A; Sasaki H; Sakata M; Tasaka K; Murata Y
    Maturitas; 2007 Apr; 56(4):343-9. PubMed ID: 17010541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss.
    Mizunuma H; Shiraki M; Shintani M; Gorai I; Makita K; Itoga S; Mochizuki Y; Mogi H; Iwaoki Y; Kosha S; Yasui T; Ishihara O; Kurabayashi T; Kasuga Y; Hayashi K
    J Bone Miner Metab; 2006; 24(1):11-5. PubMed ID: 16369892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of morphological measurements extracted from digitized dental radiographs with lumbar and femoral bone mineral density measurements in postmenopausal women.
    Shrout MK; Hildebolt CF; Potter BJ; Brunsden TK; Pilgram TK; Dotson M; Yokoyama-Crothers N; Hauser J; Cohen S; Kardaris E; Civitelli R; Hanes P
    J Periodontol; 2000 Mar; 71(3):335-40. PubMed ID: 10776919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of nutritional calcium and HRT in prevention of postmenopausal bone loss: a prospective study.
    Sirola J; Kröger H; Sandini L; Tuppurainen M; Jurvelin JS; Saarikoski S; Honkanen R
    Calcif Tissue Int; 2003 Jun; 72(6):659-65. PubMed ID: 14562993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M; Härmä K; Komulainen M; Kiviniemi V; Kröger H; Honkanen R; Alhava E; Jurvelin J; Saarikoski S
    Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on bone mass after eight years of hormonal replacement therapy.
    Eiken P; Nielsen SP; Kolthoff N
    Br J Obstet Gynaecol; 1997 Jun; 104(6):702-7. PubMed ID: 9197874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
    Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
    Trémollieres FA; Pouilles JM; Ribot C
    Osteoporos Int; 2001; 12(5):385-90. PubMed ID: 11444087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women.
    Neele SJ; Evertz R; De Valk-De Roo G; Roos JC; Netelenbos JC
    Bone; 2002 Apr; 30(4):599-603. PubMed ID: 11934652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
    Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
    Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
    Insua A; Negri A; Zanchetta JR
    Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis.
    Rehman Q; Lang TF; Arnaud CD; Modin GW; Lane NE
    Osteoporos Int; 2003 Jan; 14(1):77-81. PubMed ID: 12577188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of bone loss in peri- and postmenopausal women: a 4 year, prospective, population-based study.
    Young R; May H; Murphy S; Grey C; Compston JE
    Clin Sci (Lond); 1996 Sep; 91(3):307-12. PubMed ID: 8869413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.